GlassScriptPhysician profile
Chris W Pan
NPI 1841515509
$2,158.95
in general payments reported to CMS, 2019-2025
16 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $145 · 2021: $177 · 2022: $63.06 · 2023: $71.01 · 2024: $163 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $468.75 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $406.03 | 2019-2025 | Wainua, Farxiga |
| Aop Health US, LLC | $267.83 | 2025 | Rapiblyk |
| Abbott Laboratories | $236.27 | 2019-2023 | Portico |
| E.R. Squibb & Sons, L.L.C. | $168.99 | 2019-2025 | Camzyos |
| Pfizer INC. | $101.02 | 2021-2025 | |
| Scpharmaceuticals INC. | $91.32 | 2025 | |
| Lantheus Medical Imaging, INC. | $79.75 | 2023-2025 | Definity |
| Novartis Pharmaceuticals Corporation | $62.40 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.30 | 2025 | Jardiance |
| Boston Scientific Corporation | $49.25 | 2024 | Watchman Flx |
| Edwards Lifesciences Corporation | $45.44 | 2020 | |
| Janssen Pharmaceuticals, INC | $43.76 | 2020 | |
| Kestra Medical Technology Services, INC. | $27.49 | 2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $25.39 | 2025 | Attruby |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $22.96 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.